Spectrum Strategic Capital Management LLC Invests $729,000 in The Ensign Group, Inc. $ENSG

Spectrum Strategic Capital Management LLC purchased a new stake in shares of The Ensign Group, Inc. (NASDAQ:ENSG) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 4,185 shares of the company’s stock, valued at approximately $729,000.

Several other institutional investors also recently added to or reduced their stakes in ENSG. Private Trust Co. NA grew its position in The Ensign Group by 156.5% during the fourth quarter. Private Trust Co. NA now owns 159 shares of the company’s stock valued at $28,000 after buying an additional 97 shares during the period. Harbor Investment Advisory LLC grew its position in shares of The Ensign Group by 125.6% during the 4th quarter. Harbor Investment Advisory LLC now owns 194 shares of the company’s stock valued at $34,000 after acquiring an additional 108 shares during the period. Root Financial Partners LLC bought a new position in shares of The Ensign Group during the 3rd quarter valued at approximately $35,000. Larson Financial Group LLC grew its position in shares of The Ensign Group by 76.9% during the 3rd quarter. Larson Financial Group LLC now owns 207 shares of the company’s stock valued at $36,000 after acquiring an additional 90 shares during the period. Finally, Caitlin John LLC bought a new stake in shares of The Ensign Group in the 3rd quarter worth approximately $39,000. Institutional investors own 96.12% of the company’s stock.

Insider Buying and Selling at The Ensign Group

In other The Ensign Group news, Director Daren Shaw sold 1,000 shares of the company’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $213.43, for a total transaction of $213,430.00. Following the sale, the director directly owned 23,726 shares of the company’s stock, valued at $5,063,840.18. This represents a 4.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Barry M. Smith sold 700 shares of the stock in a transaction dated Monday, May 4th. The stock was sold at an average price of $182.21, for a total transaction of $127,547.00. Following the completion of the sale, the director directly owned 22,052 shares in the company, valued at approximately $4,018,094.92. The trade was a 3.08% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 4,242 shares of company stock valued at $862,154 in the last three months. 4.00% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts recently commented on ENSG shares. UBS Group set a $230.00 price target on shares of The Ensign Group and gave the stock a “buy” rating in a report on Friday, February 6th. Zacks Research cut shares of The Ensign Group from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th. Wall Street Zen raised shares of The Ensign Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of The Ensign Group in a report on Tuesday, April 21st. Finally, Truist Financial set a $215.00 price target on shares of The Ensign Group and gave the stock a “hold” rating in a report on Friday, February 6th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $216.75.

The Ensign Group Price Performance

NASDAQ ENSG opened at $177.67 on Monday. The company has a market cap of $10.38 billion, a PE ratio of 28.94, a price-to-earnings-growth ratio of 1.74 and a beta of 0.73. The Ensign Group, Inc. has a 52 week low of $134.79 and a 52 week high of $218.00. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.06. The firm’s 50-day simple moving average is $195.57 and its two-hundred day simple moving average is $188.91.

The Ensign Group (NASDAQ:ENSG) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.85 EPS for the quarter, beating the consensus estimate of $1.79 by $0.06. The business had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.40 billion. The Ensign Group had a net margin of 6.89% and a return on equity of 16.78%. The company’s revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.52 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. Research analysts predict that The Ensign Group, Inc. will post 6.79 earnings per share for the current year.

The Ensign Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st were issued a dividend of $0.065 per share. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $0.26 annualized dividend and a yield of 0.1%. The Ensign Group’s dividend payout ratio is 4.23%.

About The Ensign Group

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.